Gerald T Proehl's Net Worth
$30.4 Million
Who is Gerald T Proehl?
Gerald T Proehl has an estimated net worth of $30.4 Million. This is based on reported shares across multiple companies, which include SOPHIRIS BIO INC., Auspex Pharmaceuticals, Inc., RITTER PHARMACEUTICALS INC, TENAX THERAPEUTICS, INC., Dermata Therapeutics, Inc., SANTARUS INC, and DEPOMED INC.
SEC CIK
Gerald T Proehl's CIK is 0001279191
Past Insider Trading and Trends
2021 was Gerald T Proehl's most active year for acquiring shares with 14 total transactions. Gerald T Proehl's most active month to acquire stocks was the month of February. 2006 was Gerald T Proehl's most active year for disposing of shares, totalling 70 transactions. Gerald T Proehl's most active month to dispose stocks was the month of December. 2014 saw Gerald T Proehl paying a total of $1,063,480.67 for 269,601 shares, this is the most they've acquired in one year. In 2014 Gerald T Proehl cashed out on 3,218,161 shares for a total of $80,368,152.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SOPHIRIS BIO INC. No price found
InvestorGerald T Proehl owns 10,000 units of Common Stock. From 2014 to 2019 Gerald T Proehl acquired a total of 10,000 shares in SOPHIRIS BIO INC. at a cost of $31,599.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
∞
| 10K |
$3.16 | $31,599.00 | 10K |
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Auspex Pharmaceuticals, Inc. No price found
InvestorGerald T Proehl used to own units in Common Stock but no longer holds any shares there. In the year 2014 Gerald T Proehl acquired a total of 1,466 shares in Auspex Pharmaceuticals, Inc. at a cost of $31,885.35, Gerald also disposed a total of 1,466 shares of Auspex Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.47K |
—
|
—
|
0
|
May 5
| |||
Form 4
|
∞
| 1.47K |
$21.75 | $31,885.35 | 1.47K |
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RITTER PHARMACEUTICALS INC (QLGN) Snapshot price: $0.499899
InvestorGerald T Proehl owns 50,000 units of Common Stock which is worth $24,994.95. From 2015 to 2018 Gerald T Proehl acquired a total of 50,000 shares in RITTER PHARMACEUTICALS INC at a cost of $250,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
∞
| 50K |
$5.00 | $250,000.00 | 50K |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TENAX THERAPEUTICS, INC. (TENX) Snapshot price: $16.145
InvestorGerald T Proehl owns 29,882 units of Common Stock which is worth $482,444.89. From 2016 to 2022 Gerald T Proehl acquired a total of 29,882 shares in TENAX THERAPEUTICS, INC. at a cost of $49,968.71.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
∞
| 29.88K |
$1.67 | $49,968.71 | 29.88K |
Nov 22 - Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermata Therapeutics, Inc. (DRMA) Snapshot price: $0.4445
President, CEO and ChairmanGerald T Proehl owns 3,180,465 units of Common Stock which is worth $1,413,716.69. In the year 2021 Gerald T Proehl acquired a total of 2,223,636 shares in Dermata Therapeutics, Inc. at a cost of $97,631.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +50.62% | 20K |
$2.40 | $48,000.00 | 59.51K |
Nov 23
| |||
Form 4
| +240.23% | 2.2M |
$4.96 |
—
| 3.12M |
Aug 16 - Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||